ArticleFrontiers in pharmacology2025

A single-center, randomized, open-label, two-period, crossover, fasted bioequivalence study: comparing recombinant human follicle-stimulating hormone for injection (JZB30) with Gonal-f® in healthy Chinese female participants.

Zhuo Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.